KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nu Skin Enterprises (NUS) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Nu Skin Enterprises (NUS) over the last 12 years, with Q4 2024 value amounting to $385700.0.

  • Nu Skin Enterprises' Gains from Sales and Divestitures rose 1320.81% to $385700.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $385700.0, marking a year-over-year increase of 1320.81%. This contributed to the annual value of $385700.0 for FY2024, which is 1320.81% up from last year.
  • According to the latest figures from Q4 2024, Nu Skin Enterprises' Gains from Sales and Divestitures is $385700.0, which was up 1320.81% from $340700.0 recorded in Q4 2023.
  • In the past 5 years, Nu Skin Enterprises' Gains from Sales and Divestitures registered a high of $385700.0 during Q4 2024, and its lowest value of $220100.0 during Q4 2020.
  • In the last 5 years, Nu Skin Enterprises' Gains from Sales and Divestitures had a median value of $326600.0 in 2022 and averaged $316140.0.
  • In the last 5 years, Nu Skin Enterprises' Gains from Sales and Divestitures skyrocketed by 3975.47% in 2021 and then soared by 431.72% in 2023.
  • Quarter analysis of 5 years shows Nu Skin Enterprises' Gains from Sales and Divestitures stood at $220100.0 in 2020, then skyrocketed by 39.75% to $307600.0 in 2021, then grew by 6.18% to $326600.0 in 2022, then increased by 4.32% to $340700.0 in 2023, then increased by 13.21% to $385700.0 in 2024.
  • Its Gains from Sales and Divestitures stands at $385700.0 for Q4 2024, versus $340700.0 for Q4 2023 and $326600.0 for Q4 2022.